Publication Name	World Journal of Clinical Cases
Manuscript ID	72092
Country	China

Received	2021-10-05 01:11
Peer-Review Started	2021-10-05 01:12
To Make the First Decision
Return for Revision	2021-10-22 10:33
Revised	2021-10-25 14:03
Second Decision	2022-01-24 03:54
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-01-25 03:05
Articles in Press	2022-01-25 03:05
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-02-18 10:07
Publish the Manuscript Online	2022-03-02 04:52

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Meta-Analysis
Article Title	Prognostic value of YKL-40 in colorectal carcinoma patients: A meta-analysis
Manuscript Source	Unsolicited Manuscript
All Author List	Jian Wang, Shi Qi, Yu-Bing Zhu and Lei Ding
ORCID	Author(s) ORCID Number Jian Wang http://orcid.org/0000-0002-4852-9822 Shi Qi http://orcid.org/0000-0003-1994-8574 Yu-Bing Zhu http://orcid.org/0000-0001-5868-3279 Lei Ding http://orcid.org/0000-0001-7350-8508
Funding Agency and Grant Number
Corresponding Author	Lei Ding, MD, Professor, Colorectal Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Tieyi Road 10, Haidian District, Beijing 100038, China. dinglei1005@126.com
Key Words	YKL-40; Colorectal carcinoma; Prognosis; Meta-analysis
Core Tip	Our study demonstrated that YKL-40 was significantly associated with poor OS (P < 0.001) and PFS (P = 0.001). Subgroup analysis stratified by the treatment, tumor type and source of YKL-40 showed similar results. Elevated serum/plasma concentration of YKL-40 or positive expression in tumor cells was related with worse prognosis of colorectal carcinoma patients. YKL-40 might serve as a novel and reliable indicator for the evaluation of prognosis in colorectal cancer.
Publish Date	2022-03-02 04:52
Citation	Wang J, Qi S, Zhu YB, Ding L. Prognostic value of YKL-40 in colorectal carcinoma patients: A meta-analysis. World J Clin Cases 2022; 10(7): 2184-2193
URL	https://www.wjgnet.com/2307-8960/full/v10/i7/2184.htm
DOI	https://dx.doi.org/10.12998/wjcc.v10.i7.2184

Full Article (PDF)	WJCC-10-2184.pdf
Full Article (Word)	WJCC-10-2184.docx
PRISMA 2009 Checklist	72092-PRISMA-2009-Checklist-revision.doc
Manuscript File	72092_Auto_Edited-LJH.docx
Answering Reviewers	72092-Answering reviewers.pdf
Audio Core Tip	72092-Audio core tip.mp3
Biostatistics Review Certificate	72092-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	72092-Conflict-of-interest statement.pdf
Copyright License Agreement	72092-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	72092-Language certificate.pdf
Peer-review Report	72092-Peer-review(s).pdf
Scientific Misconduct Check	72092-Bing-Liu JH-2.jpg
Scientific Misconduct Check	72092-CrossCheck.jpg
Scientific Editor Work List	72092-Scientific editor work list.pdf